Wintergerst, Maximilian W. M.
Gorgi Zadeh, Shekoufeh
Wiens, Vitalis
Thiele, Sarah
Schmitz-Valckenberg, Steffen
Holz, Frank G.
Finger, Robert P.
Schultz, Thomas
Article History
Received: 29 November 2019
Accepted: 3 March 2020
First Online: 30 April 2020
Change Date: 19 July 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-94752-x
Competing interests
: M.W.M.W.: Heine Optotechnik GmbH (research material, consultant), Digisight Technologies (research material, travel reimbursements), D-EYE (research material), Carl Zeiss Meditec (research material), CenterVue (research material), Heidelberg Engineering (research material), Optos (research material); S.G.Z.: nothing to disclose; V.W.: nothing to disclose; S.T.: Bayer (honoraria/travel reimbursement), Carl Zeiss Meditec (financial support), CenterVue (financial support), Heidelberg Engineering (financial support, honoraria/travel reimbursement), Novartis (honoraria/travel reimbursement), Optos (financial support); S.S.: Acucela (financial support), Alcon/Novartis (consultant, financial support, honoraria/travel reimbursement), Allergan (consultant, financial support, honoraria/travel reimbursement), Bayer (financial support, honoraria/travel reimbursement), Bioeq/Formycon (financial support, consultant), Carl Zeiss MedicTec (financial support, honoraria/travel reimbursement), CenterVue (financial support), Galimedix (consultant), Genentech/Roche (financial support, honoraria/travel reimbursement), Heidelberg Engineering (financial support), Katairo (financial support), Optos (financial support); F.G.H.: Heidelberg Engineering (financial support, consultant), Novartis (financial support, honoraria/travel reimbursement), Bayer (financial support, honoraria/travel reimbursement), Genetech (financial support, honoraria/travel reimbursement), Acucela (financial support, honoraria/travel reimbursement), Boehringer Ingelheim (honoraria/travel reimbursement), Alcon (financial support, honoraria/travel reimbursement), Allergan (financial support, honoraria/travel reimbursement), Optos (financial support, honoraria/travel reimbursement), Carl Zeiss MediTec (financial support); R.P.F.: Heidelberg Engineering (financial support), Optos (financial support), Carl Zeis Meditec (financial support), CenterVue (financial support), Novartis (financial support, consultant), Bayer (financial support, consultant), Ellex (consultant), Santhera (consultant), RetinaImplant (consultant), Opthea (consultant); T.S.: nothing to disclose;